• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者的降脂治疗

[Lipid lowering therapy in geriatric patients].

作者信息

Lechleitner M

机构信息

Landeskrankenhaus Hochzirl, Anna-Dengel-Haus, 6170 Zirl, Österreich.

出版信息

Z Gerontol Geriatr. 2013 Aug;46(6):577-85; quiz 586-7. doi: 10.1007/s00391-013-0516-6.

DOI:10.1007/s00391-013-0516-6
PMID:23955359
Abstract

Cardiovascular disease is also the most frequent cause of mortality in the elderly population. Invasive diagnostic and therapeutic interventions are performed at an increasing rate in older patients in order to maintain functional capacities and, thus, an adequate quality of life. Thus, strategies to prevent cardiovascular events (e.g., lipid lowering therapy) are also of great importance in elderly. With respect to the side effects of statin therapy, the risk of drug interaction has to be considered, as well as myopathy. Discrepant study results exist about the influence of statins on cognitive function. Retrospective analyses indicate that statin therapy might be related to an increased risk for type.2 diabetes in certain risk groups. The indication for statin therapy should, therefore, consider the risk profile and especially the individual situation of the older patient.

摘要

心血管疾病也是老年人群中最常见的死亡原因。为了维持功能能力并进而保持足够的生活质量,侵入性诊断和治疗干预在老年患者中的实施率正在不断提高。因此,预防心血管事件的策略(如降脂治疗)在老年人中也非常重要。关于他汀类药物治疗的副作用,必须考虑药物相互作用的风险以及肌病。关于他汀类药物对认知功能的影响,存在不一致的研究结果。回顾性分析表明,他汀类药物治疗可能与某些风险组中2型糖尿病风险增加有关。因此,他汀类药物治疗的适应症应考虑风险状况,尤其是老年患者的个体情况。

相似文献

1
[Lipid lowering therapy in geriatric patients].老年患者的降脂治疗
Z Gerontol Geriatr. 2013 Aug;46(6):577-85; quiz 586-7. doi: 10.1007/s00391-013-0516-6.
2
Lipid-lowering drug therapy in elderly patients.老年患者的降脂药物治疗。
Curr Pharm Des. 2011;17(9):877-93. doi: 10.2174/138161211795428803.
3
Do patients on statins also need niacin?服用他汀类药物的患者也需要烟酸吗?
JAAPA. 2013 Jul;26(7):9-10. doi: 10.1097/01.jaa.0000431517.43690.5d.
4
Statin therapy in the elderly: a review.老年患者的他汀类药物治疗:综述。
Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):114-8. doi: 10.1016/j.archger.2008.12.012. Epub 2009 Feb 13.
5
Statins and risk of new-onset diabetes mellitus.他汀类药物与新发糖尿病风险
Circulation. 2012 Oct 30;126(18):e282-4. doi: 10.1161/CIRCULATIONAHA.112.122135.
6
Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry.对纳入PROFILE注册研究的心血管疾病患者降脂治疗及影响他汀类药物服用规律性因素的分析。
Rev Port Cardiol. 2015 Feb;34(2):111-6. doi: 10.1016/j.repc.2014.08.021. Epub 2015 Feb 3.
7
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
8
Lipid lowering for secondary prevention of cardiovascular disease in older adults.老年人心血管疾病二级预防的降脂治疗。
Drugs Aging. 2010 Dec 1;27(12):959-72. doi: 10.2165/11539550-000000000-00000.
9
A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.重新评估用降胆固醇药物靶向治疗的风险和获益。
Drugs. 2013 Jul;73(10):1025-54. doi: 10.1007/s40265-013-0072-9.
10
Pravastatin: an evidence-based statin?普伐他汀:一种基于证据的他汀类药物?
Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):821-5. doi: 10.1517/17425255.4.6.821.

本文引用的文献

1
Is type 2 diabetes really a coronary heart disease risk equivalent?2 型糖尿病真的等同于冠心病的发病风险吗?
Vascul Pharmacol. 2013 Jul-Aug;59(1-2):11-8. doi: 10.1016/j.vph.2013.05.003. Epub 2013 May 20.
2
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).短期强化他汀治疗与标准他汀治疗后斑块脂质含量的变化:YELLOW 试验(强化降脂治疗减少黄色斑块)。
J Am Coll Cardiol. 2013 Jul 2;62(1):21-9. doi: 10.1016/j.jacc.2013.03.058. Epub 2013 May 1.
3
Statins for the primary prevention of cardiovascular disease.
他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
4
Fat-free mass and fasting glucose values in patients with and without statin therapy assigned to age groups between <60 and >75 years.在年龄组<60 至>75 岁之间的他汀类药物治疗和未接受他汀类药物治疗的患者中,无脂肪质量和空腹血糖值。
Obes Facts. 2013;6(1):9-16. doi: 10.1159/000348573. Epub 2013 Feb 21.
5
Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials.他汀类药物治疗与缺血性卒中结局:观察性研究和随机试验的系统评价和荟萃分析。
Stroke. 2013 Feb;44(2):448-56. doi: 10.1161/STROKEAHA.112.668277. Epub 2013 Jan 3.
6
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.执行摘要:《2013年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):143-52. doi: 10.1161/CIR.0b013e318282ab8f.
7
Severe familial hypercholesterolaemia: current and future management.家族性高胆固醇血症:现状与未来管理。
Arch Cardiovasc Dis. 2012 Dec;105(12):656-65. doi: 10.1016/j.acvd.2012.05.011. Epub 2012 Oct 6.
8
Use of statins in lower extremity artery disease: a review.他汀类药物在下肢动脉疾病中的应用:综述
BMC Surg. 2012;12 Suppl 1(Suppl 1):S15. doi: 10.1186/1471-2482-12-S1-S15. Epub 2012 Nov 15.
9
Exploring the factors that affect blood cholesterol and heart disease risk: is dietary cholesterol as bad for you as history leads us to believe?探讨影响血液胆固醇和心脏病风险的因素:饮食中的胆固醇真像我们过往认为的那样对健康有害吗?
Adv Nutr. 2012 Sep 1;3(5):711-7. doi: 10.3945/an.111.001321.
10
Emphasizing statin safety in the hospitalized patient: a review.强调住院患者的他汀类药物安全性:综述。
Am J Med. 2012 Sep;125(9):845-53. doi: 10.1016/j.amjmed.2012.02.022.